Logo image
Chapter 1 - Induced pluripotent stem cells: novel concepts for respiratory disease modeling
Book chapter

Chapter 1 - Induced pluripotent stem cells: novel concepts for respiratory disease modeling

Ben A Calvert, Zareeb Lorenzana, Christiana N. Senger, Che-Yu Hsu, Shana N. Busch, Sinem Koc-Gunel, Erik J. Quiroz and Amy L. Ryan
Novel Concepts in iPSC Disease Modeling, pp.1-58
Elsevier Inc
2022
DOI: 10.1016/B978-0-12-823882-0.00003-5

View Online

Abstract

The past decade has witnessed the advent of induced pluripotency and methodology to direct these pluripotent stem cells to differentiate into many tissue-specific cell types, including those comprising the respiratory epithelium. Induced pluripotent stem cell-derived, (iPSC-derived), airway cells have expanded our capacity to replicate both respiratory development and disease. These relevant and reproducible models provide options to study disease-specific changes occurring in humans, which rodent models often do not readily recapitulate. Not only do these models use human cells, but they can also be patient-specific or engineered to reflect precise disease-causing mutations in controlled and isogenic cellular systems. Such advances represent a new era of precision medicine approaches for the evaluation and treatment of respiratory disease. This chapter presents a summary of recent advances in the generation of iPSC-derived cells, and their use in modeling human respiratory disease.
Cystic Fibrosis Stem Cells Airways Alveolar Differentiation Idiopathic pulmonary fibrosis Induced pluripotent stem cells Lung development Organoids Primary ciliary dyskinesia

Details

Metrics

28 Record Views
Logo image